【医药.Market】“双抗”变“单抗”合理吗?
CN-Healthcare,
P2Y12受体拮抗药在长期治疗中的心血管风险和出血风险获益使其在长期抗血小板治疗中具有越来越重要的作用,P2Y12受体拮抗药的临床治疗地位正在逐渐提升。 在使用阿司匹林的基础上加用P2Y12受体拮抗剂对接受冠状动脉介入治疗术(PCI)的患者有明确获益,被称为…
P2Y12受体拮抗药在长期治疗中的心血管风险和出血风险获益使其在长期抗血小板治疗中具有越来越重要的作用,P2Y12受体拮抗药的临床治疗地位正在逐渐提升。 在使用阿司匹林的基础上加用P2Y12受体拮抗剂对接受冠状动脉介入治疗术(PCI)的患者有明确获益,被称为…
A large clinical trial funded by Astra-Zeneca compared the safety between two blood thinners – clopidogrel and ticagrelor.
NEW ORLEANS – In STEMI patients who aren’t able to undergo primary PCI, ticagrelor after fibrinolytic therapy offered no…
Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning…
Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning…
Patients given clot busters to treat a heart attack fared equally well if they were given the standard blood thinning…